<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have shown that exposure of neurons to opioid immediately before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induces <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> tolerance </plain></SENT>
<SENT sid="1" pm="."><plain>This phenomenon is called <z:hpo ids='HP_0011009'>acute</z:hpo> opioid preconditioning </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we test the hypothesis that opioids induce delayed neuropreconditioning (from hours to days after opioid exposure) </plain></SENT>
<SENT sid="3" pm="."><plain>Exposure to <z:chebi fb="71" ids="17303">morphine</z:chebi>, an <z:chebi fb="4" ids="48705">agonist</z:chebi> for delta-, mu-, and kappa-opioid receptors, or Tan-67, a selective delta1-receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, for 30 minutes at 24 hours before a 35-minute oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD, to simulate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in vitro) dose-dependently reduced the OGD-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in the CA1 region of the rat organotypic hippocampal slice cultures </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="71" ids="17303">morphine</z:chebi> preconditioning-induced neuroprotection was inhibited by beta-funaltrexamine, a mu-opioid receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, but not by 7-benzylidenenaltrexone, a delta1-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, or nor-binaltorphimine, a kappa-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The Tan-67 preconditioning-induced neuroprotection was inhibited by 7-benzylidenenaltrexone </plain></SENT>
<SENT sid="6" pm="."><plain>The combination of <z:chebi fb="71" ids="17303">morphine</z:chebi> and Tan-67 did not induce a better preconditioning effect than did <z:chebi fb="71" ids="17303">morphine</z:chebi> or Tan-67 alone </plain></SENT>
<SENT sid="7" pm="."><plain>Application of <z:chebi fb="71" ids="17303">morphine</z:chebi> and Tan-67 at 24 hours before permanent right middle cerebral <z:mp ids='MP_0006134'>arterial occlusion</z:mp> reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improved neurologic functional outcome assessed 24 hours after the occlusion in adult male rats </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that <z:chebi fb="71" ids="17303">morphine</z:chebi> and Tan-67 induce a delayed preconditioning effect in the brain under in vivo and in vitro conditions </plain></SENT>
<SENT sid="9" pm="."><plain>Whereas the delayed phase of <z:chebi fb="71" ids="17303">morphine</z:chebi> preconditioning may involve mu-opioid receptors, Tan-67 preconditioning may be mediated by delta1-opioid receptors </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="71" ids="17303">Morphine</z:chebi> and Tan-67 may activate a shared intracellular signaling pathway to induce the delayed preconditioning effects in the brain </plain></SENT>
</text></document>